Welcome to MyStrategist, the digital home for Market Pathways.

Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically. Subscribe Today

Browse   Latest Issue

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Pathways' Picks

Breakthrough Bill Optimism, EU Reform Talk, Malaysia Joins MDSAP

In this week’s Pathways Picks: AdvaMed CEO Scott Whitaker is increasingly optimistic on legislative prospects for jumpstarting Medicare coverage of Breakthrough Devices; FDA officially rescinds the laboratory developed test rule, and refines its emergency policies for diagnostics; EU industry weighs in on short- and long-term MDR and IVDR reform; Malaysia joins the Medical Device Single Audit Program; China adds flexibility on device lab testing; and more news from Asia, Europe, and the US.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More
Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Regulatory & Reimbursement

Pathways Document Depot: Cataloging Medtech Policy

A sortable and searchable running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.

Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.

Subscribe Now   Learn More